Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab. Voprosy onkologii, v. 70, n. 6, p. 1096–1105, 22 Jan.2025.